Midweek Options Review & More

Midweek Options Review 

We offered up a buffet of options choices yesterday, and two of our ideas panned out immediately, with our longer-term idea still needing some time to mature.

The ones that worked out without delay were the designated ideas from the DBI and CONN chains. They were the DBI 12/20 $17.50-15 Puts and the CONN 12/20 $17-15 Puts.  Both of those were bearish signals on puts, and both yielded solid intraday results, good for opportunities to score the following daily gains:

Designer Brands, Inc. DBI 12/20 $17.50-15 Puts
$17.50 Puts – Range: 2.60-3.71 – Max Gain: 43%
$15 Puts – Range: .60-1.36 – Max Gain: 127%

Conn’s Inc. CONN 12/20 $17-15 Puts
$17 Puts
 – Range: 2.00-3.30 – Max Gain: 43%
$16 Puts – Range: 1.45-1.92 – Max Gain: 32%
$15 Puts – Range: .70-1.60 – Max Gain: 129%
______

Fresh Ideas
HOME 03/20 $5.00-7.00 Calls
CHWY Weekly $25.50-26 Calls
PLCE Weekly $61-59 Puts 


Extended Watchlist: 
NVUS, TYHT, KNSA, CNST, BDSI, XBIT, QFIN

Blue Horseshoe Stocks: PNTV, XBIT Recaps & More

The Players Network, Inc. PNTV

PNTV is a stock that we were talking about quite a bit late last year and in the beginning of 2017, and since then, the stock has made some really impressive moves.

In the span of one quarter, from March until June, the stock has risen from lows at .0232 to trade as high as .1315. That’s an incredible upswing of 466%

While many plays in the cannabis space have seen some unexpected difficulty this year, PNTV is not one of them. They recently announced progression on the joint venture they have going with MCIG on the construction of a Vegas-based grow facility.


Xbiotech, Inc. XBIT

We tagged XBIT in yesterday’s extended watchlist, and subsequently bore witness to a solid early-morning pop. The stock ran from 3.75 to 5.61 right from the starting the gate, banging out a solid 51% pop inside of the first hour of trading.

We also have to remember that in XBIT, we have a stock that was trading just a hair shy of $20 as recently as March. We’ll have to be on the lookout in the event that the recent rebound mounted by the stock is just a foreshadowing of an even larger recovery.



Ability, Inc. ABIL

We’ve been mentioning ABIL each day since last Wednesday, and it turned out to be a really nice bottom-bouncer.

We’ve thus far witnessed two definitive swings from ABIL; initially from.6298-1.69 for a 168% run, and then a dip to .90 followed by a run back to 1.60 in premarket trading today. That added another 78% swing to what we’ve observed in ABIL.

We’d like to see it set a higher low, holding the 1.15-1.25 range on any pullbacks in order to remain interested.


Extended Watchlist:
RTTR, NURO, MNGA, PULM BABA, FB, AMZN, NFLX

Blue Horseshoe Stocks: DCTH Review & More

Delcath Systems, Inc. DCTH
We flagged DCTH in Friday’s premarket reportas a prime bottom-bounce candidate that could be in line for a serious rebound, and even despite the markets as a whole taking a gut punch, it ended up being a great single-session play, and the NASDAQ’s top gainer.

From an early low of .0501 the stock surged as high as .0845, which works out to an intraday rise of 69% and it occurred on more than ten times the 30-day average volume, with DCTH logging its second-highest daily volume of all time.

We’d say our timing was extremely fortuitous on this rebound play, and with the kind price action and liquidity that we witnessed Friday, we’ll definitely be interested to see how the action unfolds to kick off this new trading week.


TrovaGene, Inc. TROV

We wanted to make mention of TROV this morning after noticing a cherry of a PR buzzing over the newswires. The company announced an agreement to provide tests and services for pharma giant AstraZeneca.

Whenever we see one of these smaller pharma company’s have joint news with a big player in the sector, we always want to pay attention to the stock. A perfect example of this is Pieris Pharmaceuticals, Inc. PIRS, which we signaled back on May 4th when that company also had news tying it to none other than AstraZeneca. What followed was a 55% run lasting nearly a month that took it from 3.26 the following day to a high of 5.06 last Monday, the 31st.

On the chance that TROV experiences a similar bullish push on the heels of its own AstraZeneca announcement, we’re going to be sure to have this one on watch in coming sessions.


Ascena Retail Group, Inc. ASNA

We’re also taking notice of a nice technical setup on ASNA, which owns the Lane Bryant retail brand among others, and was another of the NASDAQ’s top gainers of the day on Friday.

The activity came in the wake of a rather disappointing earnings release in terms of financials, but investors clearly responded well to the company outlook moving forward.

As you can see on the included snapshot, the stock picked up speed in its recent ascent off of a bottom, and began to fill a gap on the chart to the upside. We also have a number of other indicators pointing to a possible continued uptrend, so we’ll afford this stock a slot on our watchlist.


Extended Watchlist:
XBIT, DXTR, RWLK, ABIL, ADHD, ENRJ